GeneDx Holdings Corp. (WGS) — Financial Flexibility Index
GeneDx Holdings Corp. (WGS) has a Financial Flexibility Index of -0.08x as of June 2026. Free cash flow of $-18.87 Million (operating CF $-28.98 Million minus capex $10.11 Million) represents 0% of total liabilities ($237.26 Million). Check GeneDx Holdings Corp. (WGS) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
GeneDx Holdings Corp. Financial Flexibility Index (2020–2025)
Historical Financial Flexibility Index trend for GeneDx Holdings Corp. across 6 annual periods. For the full cash flow conversion analysis, see GeneDx Holdings Corp. cash flow conversion.
Annual Financial Flexibility Index for GeneDx Holdings Corp. (2020–2025)
Year-by-year free cash flow to debt coverage for GeneDx Holdings Corp.. Explore GeneDx Holdings Corp. (WGS) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.20x | $52.30 Million | $33.28 Million | $262.01 Million | ▲ +251.1% |
| 2024 | -0.13x | $-23.00 Million | $-28.50 Million | $174.13 Million | ▲ +85.6% |
| 2023 | -0.91x | $-174.44 Million | $-180.15 Million | $190.74 Million | ▲ +12.5% |
| 2022 | -1.05x | $-304.83 Million | $-319.15 Million | $291.56 Million | ▼ -2.3% |
| 2021 | -1.02x | $-169.65 Million | $-190.43 Million | $165.99 Million | ▼ -313.2% |
| 2020 | -0.25x | $-61.15 Million | $-93.13 Million | $247.25 Million | — |